home / stock / huge / huge news

HUGE News and Press, FSD Pharma Inc. From 04/25/24

Stock Information
Company Name: FSD Pharma Inc.
Stock Symbol: HUGE
Market: OTC
Website: fsdpharma.com
Menu
HUGE HUGE Quote HUGE Short HUGE News HUGE Articles HUGE Message Board
Get HUGE Alerts

News, Short Squeeze, Breakout and More Instantly...
HUGE - FSD Pharma Provides Update from Celly Nu's Partnership with Six+One for unbuzzd(TM)

TORONTO, ON / ACCESSWIRE / April 25, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma "), provides an update by way of a news release issued by Celly Nutrition Corp. (" Celly Nu "), and its launching of unbuzzd™, an innovative beverage product that is scientifically ...
HUGE - InvestorNewsBreaks - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Issues Update on Celly Nu's Pending Launch of unbuzzd(TM)

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) today provided an update by way of a news release issued by Celly Nutrition Corp. (“Celly Nu”), and its launching of unbuzzd(TM), an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, ...

HUGE - FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM)

TORONTO, ON / ACCESSWIRE / April 22, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma "), provides an update by way of a news release issued by Celly Nutrition Corp. (" Celly Nu "), and its launching of unbuzzd™, an innovative beverage product that is scientifically ...

HUGE - FSD Pharma expands pipeline investigation to include weight loss and liver health products

2024-04-17 08:52:21 ET More on FSD Pharma FSD Pharma receives Nasdaq notification regarding minimum bid price deficiency Financial information for FSD Pharma Read the full article on Seeking Alpha For further details see: FSD Pharma expands pipeline inves...
HUGE - FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products

TORONTO, ON / ACCESSWIRE / April 17, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma " or the " Company "), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, announce...

HUGE - InvestorNewsBreaks - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Releases Update on Celly Nu Investment

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, is reporting on its investment in Celly Nutrition Corp. According to the report, FSA enter...

HUGE - FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption

TORONTO, ON / ACCESSWIRE / April 15, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma "), provides an update on its investment in Celly Nutrition Corp. ("Celly Nu"), a privately held Canadian company launching an innovative beverage product that can assist in Expediting Alc...
HUGE - FSD Pharma receives Nasdaq notification regarding minimum bid price deficiency

2024-04-08 05:52:10 ET More on FSD Pharma Financial information for FSD Pharma Read the full article on Seeking Alpha For further details see: FSD Pharma receives Nasdaq notification regarding minimum bid price deficiency

HUGE - InvestorNewsBreaks - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Files Q4, Year-End 2023 Financial Results

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has filed its audited annual financial results. According to the announcement, the results...

HUGE - FSD Pharma GAAP EPS of -$0.46

2024-04-02 06:00:31 ET More on FSD Pharma Financial information for FSD Pharma Read the full article on Seeking Alpha For further details see: FSD Pharma GAAP EPS of -$0.46
Previous 10 Next 10